Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Theravance Biopharma)"
Count: 73
Selected: 0
NCT IDTitle
NCT05165485Phase 4 COPD and Suboptimal Inspiratory Flow Rate
NCT05091723TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
NCT04688632Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
NCT04681079Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
NCT04589260TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis
NCT04587713Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
NCT04402866TD-0903 for ALI Associated With COVID-19
NCT04350736First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19
NCT04200573Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855
NCT04150341Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response
NCT04095793Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT04044339Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects
NCT03920254TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
NCT03829657Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT03758443Efficacy & Safety of TD-1473 in Ulcerative Colitis
NCT03750565Multiple Dose Ethnobridging PK Study in Healthy Subjects
NCT03750552Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT03652038Single and Multiple Ascending Dose Study of TD-8236 by Inhalation
NCT03635112Efficacy and Safety of TD-1473 in Crohn's Disease
NCT03555617Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
NCT03432793Drug-Drug Interaction (DDI) Study for TD-9855
NCT03408470TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
NCT03103412TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
NCT02954263Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects
NCT02903095Single Ascending Dose Study of TD-1439 in Healthy Subjects
NCT02818686TD-1473 for Active Ulcerative Colitis (UC)
NCT02709928Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects
NCT02705755TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
NCT02663089A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects
NCT02657122SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects
NCT02639078Single Ascending Dose Study of TD-0714 in Healthy Subjects
NCT02267525The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
NCT02116543TD-6450 MAD Study in HCV Infected Subjects
NCT02022306TD-6450 SAD and MAD in Healthy Subjects
NCT01949103TD-1607 MAD Study in Healthy Subjects
NCT01924143TD-9855 Mass Balance Study
NCT01791049TD-1607 SAD Study in Healthy Subjects
NCT01718938Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis
NCT01702194TD-1211 IV/Oral Mass Balance Study
NCT01693692Phase 2 Study of TD-9855 to Treat Fibromyalgia
NCT01655771TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects
NCT01644240A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects
NCT01568411A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211
NCT01467726Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
NCT01459926A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation
NCT01458340A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT01401985A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)
NCT01333540A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Constipation
NCT01040637A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation
NCT00887406Study of GSK961081 in Healthy Volunteer Subjects